Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2020

01-10-2020 | Thalassemia | Original Article

Comparison of Two High-Pressure Liquid Chromatography Instruments Bio-Rad Variant-II and Tosoh HLC-723G11 in the Evaluation of Hemoglobinopathies

Authors: Parul Chopra, Sunanda Bhardwaj, Pushkar Negi, Anil Arora

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2020

Login to get access

Abstract

Hemoglobin High-performance liquid chromatography (Hb HPLC) is a standard first-line technique for diagnosis of thalassemia and hemoglobinopathies. We compared two HPLC systems for detection and quantification of normal and abnormal Hb fractions. EDTA samples from 100 normal healthy subjects and 107 subjects affected with hemoglobinopathies or carriers were analysed using HPLC systems Tosoh HLC-723G11 and Bio-Rad Variant-II. Retention time (RT) and area of peaks for HbA2, HbF and other structural variants were compared. In discrepant cases samples were run on Sebia Capillary zone electrophoresis (CZE) for confirmation of results (39 out of 107 cases with HbE, HbD Iran, Hb Lepore and HbQ). Measurement of HbA2 and HbF in normal samples and HbF in those with variant Hbs showed good correlation by both analyzers (R2 = 0.83, 0.9 and 0.99 respectively). HbE co-elutes with HbA2 in Bio-Rad. Correlation done using the apparent HbA2 concentration from Bio-Rad with (HbE + HbA2) from Tosoh G11 showed good correlation (R2 = 0.97). Correlation of HbS (Eluting at S-window at RT 3.11 min in Tosoh G11 and 4.33 min in Bio-Rad) as well as HbD Punjab (Eluting at D-window at RT 2.82 min in Tosoh G11 and 4.06 min in Bio-Rad) by both instruments was good. HbD Iran (Eluting at E-window at RT 2.69 min in Tosoh G11 and with HbA2 at 3.53 min in Bio-Rad); HbQ (Eluting at C-window at RT 3.78 min in Tosoh G11 and unknown window at 4.7 min in Bio-Rad), HbH (Eluting at P00 window at RT 0.13 min in Tosoh G11 and giving pre-integration peak in Bio-Rad), Hb Lepore (Eluting at P08 window at RT 2.67 min in Tosoh G11 and with HbA2 at 3.46 min in Bio-Rad) gave comparable results. Correlation with findings of CZE was done in few cases when needed. Two automated HPLC instruments demonstrated similar usefulness for screening patients for hemoglobinopathies. However, complex elution patterns as well as co-elution of variants like HbA2, HbE, Hb Lepore, HbD Iran (in Bio-Rad); HbD Iran and HbE (Tosoh G11) pose difficulty in interpretation. A complementary second method like CZE may be required.
Appendix
Available only for authorised users
Literature
1.
go back to reference Keren DF, Hedstrom D, Gulbranson R, Ou C-N, Bak R (2008) Comparison of Sebia Capillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies. Am J Clin Pathol 130(5):824–831CrossRef Keren DF, Hedstrom D, Gulbranson R, Ou C-N, Bak R (2008) Comparison of Sebia Capillarys capillary electrophoresis with the Primus high-pressure liquid chromatography in the evaluation of hemoglobinopathies. Am J Clin Pathol 130(5):824–831CrossRef
2.
go back to reference Greene DN, Pyle AL, Chang JS, Hoke C, Lorey T (2012) Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies. Clin Chim Acta Int J Clin Chem 413(15–16):1232–1238CrossRef Greene DN, Pyle AL, Chang JS, Hoke C, Lorey T (2012) Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies. Clin Chim Acta Int J Clin Chem 413(15–16):1232–1238CrossRef
3.
go back to reference Sharma S, Sharma P, Das R, Chhabra S, Hira JK (2017) HbQIndia (HBA1:c.193G>C): hematological profiles and unique CEHPLC findings of potential diagnostic utility in 65 cases. Ann Hematol 96:1227–1229CrossRef Sharma S, Sharma P, Das R, Chhabra S, Hira JK (2017) HbQIndia (HBA1:c.193G>C): hematological profiles and unique CEHPLC findings of potential diagnostic utility in 65 cases. Ann Hematol 96:1227–1229CrossRef
4.
go back to reference Merono F, Agouti I, Bonello-Palot N, Paolasso C, Levy N, Badens C (2011) Analytical evaluation of the Tosoh HLC-723 G8 automated HPLC analyzer for hemoglobin analysis in beta-thalassemia mode. Clin Biochem 44(5–6):441–443CrossRef Merono F, Agouti I, Bonello-Palot N, Paolasso C, Levy N, Badens C (2011) Analytical evaluation of the Tosoh HLC-723 G8 automated HPLC analyzer for hemoglobin analysis in beta-thalassemia mode. Clin Biochem 44(5–6):441–443CrossRef
5.
go back to reference Ou C-N, Rognerud CL (2001) Diagnosis of hemoglobinopathies: electrophoresis vs HPLC. Clin Chim Acta 313(1):187–194CrossRef Ou C-N, Rognerud CL (2001) Diagnosis of hemoglobinopathies: electrophoresis vs HPLC. Clin Chim Acta 313(1):187–194CrossRef
6.
go back to reference Schroeder WA, Shelton JB, Shelton JR, Huynh V (1986) The estimation of Hb A2 in the presence of Hb C or Hb E by reverse phase high performance liquid chromatography. Hemoglobin 10(3):253–257CrossRef Schroeder WA, Shelton JB, Shelton JR, Huynh V (1986) The estimation of Hb A2 in the presence of Hb C or Hb E by reverse phase high performance liquid chromatography. Hemoglobin 10(3):253–257CrossRef
7.
go back to reference Joutovsky A (2004) HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem 50(10):1736–1747CrossRef Joutovsky A (2004) HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem 50(10):1736–1747CrossRef
Metadata
Title
Comparison of Two High-Pressure Liquid Chromatography Instruments Bio-Rad Variant-II and Tosoh HLC-723G11 in the Evaluation of Hemoglobinopathies
Authors
Parul Chopra
Sunanda Bhardwaj
Pushkar Negi
Anil Arora
Publication date
01-10-2020
Publisher
Springer India
Keyword
Thalassemia
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01298-5

Other articles of this Issue 4/2020

Indian Journal of Hematology and Blood Transfusion 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine